Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sentrana is a data science and artificial intelligence company that specializes in market-driven pricing and scientific marketing for the healthcare and consumer goods industries. The company's core offering is the DeepSymmetry platform, which utilizes behavioral economics and machine learning to provide organizations with precise insights into customer behavior and revenue optimization. In the healthcare sector, Sentrana's solutions are designed to improve health outcomes and operational performance through advanced data analytics and predictive modeling. The company has historically served a diverse range of clients, including pharmaceutical manufacturers and health insurance providers, to enhance their commercial decision-making. In January 2022, Sentrana was acquired by Legato Health Technologies, a subsidiary of Elevance Health (formerly Anthem), to bolster its digital health and AI-driven service capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sentrana.